Sg3 Management, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $112,300 - $195,900	10,000 New	10,000 $138,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $120,330 - $160,110	-9,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $116,910 - $184,230	9,000 New	9,000 $134,000
Q3 2020 Nov 13, 2020	SELL	$39.09 - $53.44 $254,085 - $347,360	-6,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $303,550 - $598,260	6,500 New	6,500 $311,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.